143 related articles for article (PubMed ID: 26102033)
1. Glucocorticoid-mediated co-regulation of RCAN1-1, E4BP4 and BIM in human leukemia cells susceptible to apoptosis.
Saenz GJ; Hovanessian R; Gisis AD; Medh RD
Biochem Biophys Res Commun; 2015 Aug; 463(4):1291-6. PubMed ID: 26102033
[TBL] [Abstract][Full Text] [Related]
2. Correlation of glucocorticoid-mediated E4BP4 upregulation with altered expression of pro- and anti-apoptotic genes in CEM human lymphoblastic leukemia cells.
Beach JA; Nary LJ; Hovanessian R; Medh RD
Biochem Biophys Res Commun; 2014 Aug; 451(3):382-8. PubMed ID: 25101525
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid induced osteoblast apoptosis by increasing E4BP4 expression via up-regulation of Bim.
Chen F; Zhang L; OuYang Y; Guan H; Liu Q; Ni B
Calcif Tissue Int; 2014 Jun; 94(6):640-7. PubMed ID: 24658772
[TBL] [Abstract][Full Text] [Related]
4. E4BP4 facilitates glucocorticoid-evoked apoptosis of human leukemic CEM cells via upregulation of Bim.
Beach JA; Nary LJ; Hirakawa Y; Holland E; Hovanessian R; Medh RD
J Mol Signal; 2011 Oct; 6(1):13. PubMed ID: 21975218
[TBL] [Abstract][Full Text] [Related]
5. RCAN1 is an important mediator of glucocorticoid-induced apoptosis in human leukemic cells.
Nagao K; Iwai Y; Miyashita T
PLoS One; 2012; 7(11):e49926. PubMed ID: 23185487
[TBL] [Abstract][Full Text] [Related]
6. Calcium-dependent upregulation of E4BP4 expression correlates with glucocorticoid-evoked apoptosis of human leukemic CEM cells.
Priceman SJ; Kirzner JD; Nary LJ; Morris D; Shankar DB; Sakamoto KM; Medh RD
Biochem Biophys Res Commun; 2006 Jun; 344(2):491-9. PubMed ID: 16630563
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells.
Heidari N; Miller AV; Hicks MA; Marking CB; Harada H
Cell Death Dis; 2012 Jul; 3(7):e349. PubMed ID: 22825467
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis.
Hirakawa Y; Nary LJ; Medh RD
J Mol Signal; 2009 Sep; 4():6. PubMed ID: 19725972
[TBL] [Abstract][Full Text] [Related]
9. Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells.
Zhao YN; Guo X; Ma ZG; Gu L; Ge J; Li Q
Med Oncol; 2011 Dec; 28(4):1609-17. PubMed ID: 20697841
[TBL] [Abstract][Full Text] [Related]
10. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
[TBL] [Abstract][Full Text] [Related]
11. The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells.
Zhang L; Insel PA
J Biol Chem; 2004 May; 279(20):20858-65. PubMed ID: 14996839
[TBL] [Abstract][Full Text] [Related]
12. Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells.
López-Royuela N; Balsas P; Galán-Malo P; Anel A; Marzo I; Naval J
Biochim Biophys Acta; 2010 Feb; 1803(2):311-22. PubMed ID: 19914305
[TBL] [Abstract][Full Text] [Related]
13. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
Hall CP; Reynolds CP; Kang MH
Clin Cancer Res; 2016 Feb; 22(3):621-32. PubMed ID: 26080839
[TBL] [Abstract][Full Text] [Related]
16. p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells.
Lu J; Quearry B; Harada H
FEBS Lett; 2006 Jun; 580(14):3539-44. PubMed ID: 16730715
[TBL] [Abstract][Full Text] [Related]
17. Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.
Espina B; Liang M; Russell RG; Hulley PA
J Cell Physiol; 2008 May; 215(2):488-96. PubMed ID: 18064628
[TBL] [Abstract][Full Text] [Related]
18. Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia.
Soh SX; Lim JY; Huang JW; Jiang N; Yeoh AE; Ong ST
PLoS One; 2014; 9(8):e103435. PubMed ID: 25090024
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
Medh RD; Wang A; Zhou F; Thompson EB
Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
[TBL] [Abstract][Full Text] [Related]
20. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
